Fast Five Quiz: Can You Properly Identify and Treat COPD?

Zab Mosenifar, MD

Disclosures

May 27, 2020

The use of systemic steroids in the treatment of acute exacerbations is widely accepted and recommended, given their high efficacy. A systematic review concluded that even patients with mild COPD exacerbations can benefit from systemic corticosteroids.

Conversely, the use of oral steroids in persons with chronic stable COPD is widely discouraged, given adverse effects that include hypertension, glucose intolerance, osteoporosis, fractures, and cataracts. Inhaled corticosteroids provide a more direct route of administration to the airways, and similar to other inhaled agents, they are only minimally absorbed. Consequently, aside from the development of thrush, the systemic adverse effects of these medications at standard doses are negligible. The current ICSI (Institute for Clinical Systems Improvement) guidelines conclude that inhaled steroids are appropriate in patients with recurrent exacerbations of COPD.

For more information on the treatment of COPD, read here.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....